瘤进展中的微环境调节:与癌症相关的纤维细胞和免疫细胞之间的相互作用
Dandan Gao1, Liguang Fang2, Cun Liu1
1College of Traditional Chinese Medicine, Weifang Medical University, Weifang 261000, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|October 2, 2023
概括
瘤微环境 (TME) 中的癌症相关纤维细胞 (CAF) 促进瘤生长和免疫逃避. 针对CAF提供了一个有希望的策略,以提高癌症免疫疗法的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 瘤微环境 (TME) 极大地影响瘤的进展和治疗反应.
- 与癌症相关的纤维细胞 (CAF) 是TME中的关键 stromal 细胞,影响瘤免疫和转移.
研究的目的:
- 综合审查CAF在TME中的多方面的作用.
- 探索纤维细胞化学反应,恶性转变,新陈代谢和免疫细胞相互作用.
- 总结当前针对CAF的小分子药物的治疗应用.
主要方法:
- 文献综述和对CAF现有研究的综合.
- 分析CAF功能,包括新陈代谢和细胞因子分泌.
- 收集针对CAF的小分子药物的数据.
主要成果:
- 通过改变免疫细胞功能和促进免疫逃生,CAFs有助于免疫抑制的TME.
- 纤维细胞的特征,如化学反应,转化和新陈代谢,对于它们的作用至关重要.
- 各种天然和向的小分子药物显示出CAF导向疗法的潜力.
结论:
- CAFs在TME中显著影响瘤进展和免疫逃避.
- 了解CAF生物学对于开发新的癌症治疗方法至关重要.
- 向CAF具有显著的希望,可以提高癌症免疫治疗的疗效.
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


